Literature DB >> 18685861

Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation.

Tomoharu Shimizu1, Kazuyoshi Hanasawa, Koichi Sato, Masahiko Umeki, Nobuhiko Koga, Tatsushi Naganuma, Seiji Sato, Tomonori Shimonishi, Toshiaki Ikeda, Naoto Matsuno, Satoshi Ono, Hitoshi Saitoh, Koshi Satoh, Yoshimasa Otani, Yoshihiro Endo, Yutaka Eguchi, Tohru Tani.   

Abstract

PURPOSE: Although some studies have reported favorable effects of direct hemoperfusion with polymyxin-B-immobilized fiber columns (PMX) for the treatment of septic shock, few studies have demonstrated the efficacy of PMX in studies with a uniform case definition and without any other blood purification techniques.
MATERIALS AND METHODS: Fifty-two patients with severe sepsis or septic shock secondary to colorectal perforation were treated with PMX. Hemodynamic alterations and plasma concentrations of endotoxin, interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1Ra), IL-6, IL-8, and IL-10 were evaluated following PMX treatment.
RESULTS: We observed a significant reduction in plasma endotoxin in the nonsurvivors immediately after PMX treatment compared to before treatment. Systolic blood pressure was markedly increased and circulating levels of IL-1beta, IL-1Ra, and IL-8 were significantly reduced during a 2-h interval of PMX.
CONCLUSIONS: Our findings suggested that PMX treatment appears to adsorb endotoxin and also modulates circulating cytokine during a 2-h interval of direct hemoperfusion in septic patients with such condition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18685861     DOI: 10.1007/s00423-008-0395-2

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  43 in total

1.  Differential gene expression of CINC, NOS II, and ICAM-1 in endotoxemic liver cells by rG-CSF.

Authors:  G A Wanner; V Stöckle; M Bauer; M D Menger; B Vollmar
Journal:  Langenbecks Arch Surg       Date:  1999-04       Impact factor: 3.445

Review 2.  Cardiovascular management of septic shock.

Authors:  R Phillip Dellinger
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

3.  The role of bacterial translocation on neutrophil activation during hemorrhagic shock in rats.

Authors:  T Shimizu; T Tani; K Hanasawa; Y Endo; M Kodama
Journal:  Shock       Date:  2001-07       Impact factor: 3.454

Review 4.  Endotoxin apheresis for sepsis.

Authors:  Tomoharu Shimizu; Yoshihiro Endo; Hiroshi Tsuchihashi; Hiroya Akabori; Hiroshi Yamamoto; Tohru Tani
Journal:  Transfus Apher Sci       Date:  2006-11-21       Impact factor: 1.764

5.  Early detection of the Limulus amebocyte lysate reaction evoked by endotoxins.

Authors:  T Obata; M Nomura; Y Kase; H Sasaki; Y Shirasawa
Journal:  Anal Biochem       Date:  2007-09-21       Impact factor: 3.365

6.  Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model.

Authors:  Mohamed Hamed Hussein; Takenori Kato; Takahiro Sugiura; Ghada A Daoud; Satoshi Suzuki; Sumio Fukuda; Hisanori Sobajima; Ineko Kato; Hajime Togari
Journal:  Pediatr Res       Date:  2005-07-08       Impact factor: 3.756

7.  A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.

Authors:  Jean-Louis Vincent; Pierre-François Laterre; Jonathan Cohen; Hilmar Burchardi; Hajo Bruining; Francisco Alvarez Lerma; Xavier Wittebole; Daniel De Backer; Stephen Brett; Dolores Marzo; Haruji Nakamura; Stephanie John
Journal:  Shock       Date:  2005-05       Impact factor: 3.454

8.  Surgical stress reduces mortality from endotoxin shock.

Authors:  Keitarou Kamei; Yuji Nimura; Masato Nagino; Keiya Aono; Izumi Nakashima
Journal:  Langenbecks Arch Surg       Date:  2001-11-23       Impact factor: 3.445

9.  A prostaglandin E2 receptor subtype EP4 agonist attenuates cardiovascular depression in endotoxin shock by inhibiting inflammatory cytokines and nitric oxide production.

Authors:  Atsuhiro Sakamoto; Junya Matsumura; Seiji Mii; Yoshitugu Gotoh; Ryo Ogawa
Journal:  Shock       Date:  2004-07       Impact factor: 3.454

10.  Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column.

Authors:  T Tani; K Hanasawa; Y Endo; T Yoshioka; M Kodama; M Kaneko; Y Uchiyama; T Akizawa; K Takahasi; K Sugai
Journal:  Artif Organs       Date:  1998-12       Impact factor: 3.094

View more
  7 in total

1.  Analysis of the efficacy of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) according to the prognostic factors in patients with colorectal perforation.

Authors:  Kiichi Sugimoto; Koichi Sato; Hiroshi Maekawa; Mutsumi Sakurada; Hajime Orita; Tomoaki Ito; Kazuhiro Sakamoto
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

Review 2.  Anti-endotoxin Properties of Polymyxin B-immobilized Fibers.

Authors:  Tohru Tani; Tomoharu Shimizu; Masaji Tani; Hisataka Shoji; Yoshihiro Endo
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

3.  Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.

Authors:  Toshiaki Iba; Isao Nagaoka; Atsushi Yamada; Masataka Nagayama; Takahiro Miki
Journal:  Int J Med Sci       Date:  2014-01-17       Impact factor: 3.738

Review 4.  Novel formulations for antimicrobial peptides.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

5.  Successful treatment of sepsis due to Pantoea agglomerans by polymyxin B-immobilized fiber column direct hemoperfusion therapy in a small cell lung carcinoma patient.

Authors:  Hironobu Tsubouchi; Nobuhiro Matsumoto; Shigehisa Yanagi; Yasuji Arimura; Masamitsu Nakazato
Journal:  Respir Med Case Rep       Date:  2016-10-06

Review 6.  History and current status of polymyxin B-immobilized fiber column for treatment of severe sepsis and septic shock.

Authors:  Tomoharu Shimizu; Toru Miyake; Masaji Tani
Journal:  Ann Gastroenterol Surg       Date:  2017-07-04

7.  Hemoperfusion in patients with severe COVID-19 respiratory failure, lifesaving or not?

Authors:  Saeed Abbasi; Zohre Naderi; Babak Amra; Abdolamir Atapour; Seyed Amir Dadkhahi; Mohammad Javad Eslami; Mohammad Reza Hajian; Marzieh Hashemi; Seyed Taghi Hashemi; Bijan Iraj; Farzin Khorvash; Samane Madadi; Hossein Mahjoubi Pour; Marjan Mansourian; Majid Rezvani; Ramin Sami; Forough Soltaninejad; Shahrzad Shahidi; Sahar Vahdat; Zahra Zamani; Firouzeh Moeinzadeh
Journal:  J Res Med Sci       Date:  2021-05-27       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.